Article Text
PDF
Statistics from Altmetric.com
L Pilote
Dr L Pilote, McGill University Health Centre, Montreal, Quebec, Canada; louise.pilote@mcgill.ca
QUESTION
Does type of angiotensin-converting enzyme (ACE) inhibitor prescribed affect mortality in elderly patients with heart failure?
METHODS
Design:
retrospective cohort study using government administrative databases, with mean follow-up of 2.1 years.
Setting:
Ontario, Quebec, and British Columbia, Canada.
Patients:
43 316 patients 65–105 years of age (median age 78 y, 52% women) who were discharged from hospital over a 4.25–year period with a primary diagnosis of heart failure, had not been admitted to hospital for this indication in the previous 3 years, and filled a prescription for an ACE inhibitor within 30 days of discharge.
Risk factor:
type …
Footnotes
Source of funding: Canadian Institutes of Health Research.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.